<DOC>
	<DOCNO>NCT01858870</DOCNO>
	<brief_summary>Lacosamide antiepileptic drug approve use like adjuvant treatment adult epileptic crisis . Previous study grant adjuvant therapy significant efficacy . This observational study , multicenter retrospective , patient epilepsy . The aim study evaluation adjuvant treatment Lacosamide administer 12 month . The investigator collect information 860 patient 13 spanish center . The secondary aim assess tolerability treatment 3,6 12 month .</brief_summary>
	<brief_title>Observational Retrospective Study Effectivity Tolerability Patients With Lacosamide Medication</brief_title>
	<detailed_description>During treatment perform analysis three different time ( 3 , 6 12 month ) obtain vision tolerability efficacy Lacosamide usual clinical practice . We intend describe difference add Lacosamide antiepileptic drug , sodium channel blocker no-sodium channel blocker usual clinical practice . Clinical data obtain post-hoc analysis register pivotal study make highly refractory epileptic patient show adjuvant treatment Lacosamide extra efficacy compare placebo . It self-depended treatment without sodium channel blocker . This study allow u obtain information real exist population exist high refractoriness pivotal study . The population study : Patients epilepsy , plus 18 year old patient , initial partial crisis treat Lacosamide accord usual clinical practice Spain . Lacosamide must use epilepsy treatment least 12 month . The data record collection 5 month . Inclusion criterion : 1 . Adults ( +18 ) . 2 . Patients epilepsy partial crisis diagnostic treat Lacosamide accord usual clinical practice . 3 . The patient least one partial crisis year initiation treatment Lacosamide . 4 . The patient legal agent reliable able adhere protocol accord investigation criterion . Exclusion criterion : 1 . Patient study medical protocol medical implant . 2 . Patients kind epilepsy . 3. patient chronic alcoholism abuse drug record last year . 4. patient n't possession faculty moment sign Informed Consent .</detailed_description>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>1 . The patient , male female , 18 year . 2 . The patient diagnosis prostate cancer kind , treat Lacosamide accord routine clinical practice . 3 . The patient least one Partial Crisis year prior initiation treatment Lacosamide . 4 . The patient legal representative reliable able adhere protocol ( ie , able understand complete interview study visit ) , discretion investigator . 1 . Patient participate another study medicinal product research ( PMI ) medical implant . 2 . Patients types epilepsy . 3 . Patients history chronic alcoholism drug abuse last year . 4 . Patients possession faculty time obtain Informed Consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Partial Crisis</keyword>
</DOC>